Brown Brothers Harriman & Co’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.84K | Buy |
+313
| New | +$4.84K | ﹤0.01% | 1277 |
|
|
2022
Q4 | – | Sell |
-1,271
| Closed | -$16K | – | 1489 |
|
|
2022
Q3 | $16K | Buy |
1,271
+286
| +29% | +$3.6K | ﹤0.01% | 1041 |
|
|
2022
Q2 | $14K | Sell |
985
-6,331
| -87% | -$90K | ﹤0.01% | 958 |
|
|
2022
Q1 | $105K | Buy |
+7,316
| New | +$105K | ﹤0.01% | 625 |
|
|
2021
Q3 | – | Sell |
-1,518
| Closed | -$26 | – | 1222 |
|
|
2021
Q2 | $26 | Buy |
1,518
+503
| +50% | +$9 | ﹤0.01% | 772 |
|
|
2021
Q1 | $19 | Sell |
1,015
-123
| -11% | -$2 | ﹤0.01% | 779 |
|
|
2020
Q4 | $21K | Hold |
1,138
| – | – | ﹤0.01% | 780 |
|
|
2020
Q3 | $20K | Hold |
1,138
| – | – | ﹤0.01% | 697 |
|
|
2020
Q2 | $20K | Sell |
1,138
-109
| -9% | -$1.92K | ﹤0.01% | 687 |
|
|
2020
Q1 | $19K | Buy |
+1,247
| New | +$19K | ﹤0.01% | 638 |
|
|
2019
Q4 | – | Sell |
-372
| Closed | -$6K | – | 1272 |
|
|
2019
Q3 | $6K | Buy |
+372
| New | +$6K | ﹤0.01% | 966 |
|
|
2019
Q2 | – | Sell |
-129
| Closed | -$3K | – | 1219 |
|
|
2019
Q1 | $3K | Buy |
129
+100
| +345% | +$2.33K | ﹤0.01% | 941 |
|
|
2018
Q4 | $0 | Buy |
+29
| New | – | ﹤0.01% | 987 |
|